Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome.
Justin
J
Stebbing
Mark
M
Atkins
Mark
M
Nelson
Shefali
S
Rajpopat
Tom
T
Newsom-Davis
Brian
B
Gazzard
Mark
M
Bower
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D006509:Hepatitis B / Q000401:mortality*; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000401:mortality*; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate
D019380:Anti-HIV Agents